- Filed
- May 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 1, 2024 | 1.28M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 1.28M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 1.27M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$754.61K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$1.88M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $5.61M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $6.36M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.41M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $8.15M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $8.48M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $7.92M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.27M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.32M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $6.99M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.77M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $10.38M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $11.88M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $10.41M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $11.92M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$3.71 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.42 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$3.71 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.42 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.83M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $2.05M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $3.17K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $62.73K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$4.75M |
| Net Income | Q1 2024 · Mar 31, 2023 | $533.09K |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$1.55M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.46M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $1.18M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $1.34M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $1.82M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $1.85M |
| Revenue | Q1 2024 · Mar 31, 2024 | $3M |
| Revenue | Q1 2024 · Mar 31, 2023 | $3.19M |
| Capex | Q1 2024 · Mar 31, 2023 | $1.65K |